Company Profile

CHO Pharma (TWSE: 6586) is a pharmaceutical company that focuses on carbohydrate-related new drug development. We apply innovative glycan technology platform to develop new drugs for infectious diseases and cancers. Hence, our company employs a double-engine business model that aims at both technology platform licensing and new drug development. Our vision is to become global leading glycan technology biotechnical pharmaceutical enterprise.

CHO Pharma is dedicated to address unmet medical needs and to deliver solutions valuable to patients through its innovative glycan engineering technologies and platforms, and brand Taiwan biotechnology in the global area.
 
As a research-oriented company committed to innovation, CHO Pharma's missions are to become a global leading biopharmaceutical company specialized on glycan-based technology, to keep sustainable growth and develop products that are beneficial to patients worldwide.